Parkinsonism induced by VNS in a child with double-cortex syndrome

Arthur Cukiert1, Pedro Paulo Mariani, Jose Augusto Burattini

  • 1Epilepsy Surgery Program, Hospital Brigadeiro, São Paulo, Brazil. acukiert@uol.com.br

Epilepsia
|August 14, 2009
PubMed

Insights

Vagus nerve stimulation (VNS) effectively reduced seizures in a child with epilepsy and double-cortex syndrome. However, increasing VNS intensity triggered parkinsonian symptoms, highlighting a direct effect on the basal ganglia.

Area of Science:

  • Neurology
  • Neurophysiology

Background:

  • Epilepsy management often involves Vagus Nerve Stimulation (VNS) for refractory cases.
  • Double-cortex syndrome is a rare neuronal migration anomaly associated with intellectual disability and epilepsy.

Observation:

  • A 13-year-old female with refractory epilepsy and double-cortex syndrome underwent VNS therapy.
  • VNS therapy led to a significant reduction in seizure frequency.
  • Progressive increases in VNS intensity correlated with the emergence of parkinsonian symptoms, including tremor, rigidity, and gait disturbances.

Findings:

  • The patient experienced reversible parkinsonian symptoms directly linked to VNS intensity.
  • Discontinuation of VNS resulted in the complete resolution of extrapyramidal symptoms.
  • This case suggests a direct impact of VNS on the basal ganglia function.

Implications:

  • VNS may have previously unrecognized direct effects on basal ganglia function.
  • Careful titration of VNS is crucial in patients with underlying neurological conditions.
  • Further research is warranted to elucidate the neurobiological mechanisms underlying VNS-induced parkinsonism.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...